SCHEMBL5820004

SCHEMBL5820004

CN(CC(CCN1CC(N2CCSCC2)C1)c1ccc(Cl)c(Cl)c1)C(=O)c1cc(C#N)cc2c1CCCC2

nearest known ligand 0.52

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
TACR2 P21452 16/20 0.52
TACR1 P25103 3/20 0.49
TACR3 P29371 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5015162 1.00 TACR2 (0.52) TACR2TACR1TACR3
Acetic Acid SCHEMBL4261883 0.98 TACR2 (0.52) TACR2TACR1TACR3
SCHEMBL6000663 0.91 TACR2 (0.52) TACR2TACR1TACR3
SCHEMBL5015235 0.91 TACR2 (0.52) TACR2TACR1TACR3
SCHEMBL4259228 0.90 TACR2 (0.40) TACR2TACR1TACR3
Acetic Acid SCHEMBL4413705 0.89 TACR2 (0.52) TACR2TACR1TACR3
SCHEMBL5801564 0.85 TACR2 (0.67) TACR2TACR1TACR3
SCHEMBL5015249 0.85 TACR2 (0.67) TACR2TACR1TACR3
SCHEMBL5011918 0.84 TACR2 (0.53) TACR2TACR1TACR3
SCHEMBL5809597 0.84 TACR2 (0.53) TACR2TACR1TACR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006062478-A1 NOVEL TREATMENT OF GASTROINTESTINAL DISORDERS ASTRAZENECA AB (SE) 2006-06-15 WO claimed
WO-2006062478-A1 NOVEL TREATMENT OF GASTROINTESTINAL DISORDERS ASTRAZENECA AB (SE) 2006-06-15 WO disclosed
EP-1636221-A2 NEW AZETIDINE COMPOUNDS AstraZeneca AB (SE) 2006-03-22 EP disclosed
WO-2004110344-A2 NEW AZETIDINE COMPOUNDS ASTRAZENECA AB (SE) 2004-12-23 WO disclosed